Clinical Trial: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Participants With Phenylketonuria

U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241234) titled 'A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-181 in Participants With Phenylketonuria' on Nov. 17.

Brief Summary: The primary purpose of this study is to assess the safety and tolerability of AG-181 in participants with Phenylketonuria (PKU).

Study Start Date: March, 2026

Study Type: INTERVENTIONAL

Condition: Phenylketonuria

Intervention: DRUG: AG-181

AG-181 film-coated tablets

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Agios Pharmaceuticals, Inc.

Disclaimer: Curated by HT Syndication....